Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1976 1
1980 1
1984 1
1985 1
1986 1
1989 1
1992 3
1994 1
1995 2
1996 2
1999 1
2000 2
2001 3
2002 3
2003 3
2004 2
2005 1
2006 6
2007 4
2008 6
2009 2
2010 1
2011 3
2012 2
2013 2
2014 5
2015 7
2016 5
2017 4
2018 2
2019 6
2020 10
2021 7
2022 6
2023 10
2024 9
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for actinic plus
Your search for actinac-plus retrieved no results
Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
Mohney L, Singh R, Grada A, Feldman S. Mohney L, et al. J Drugs Dermatol. 2022 Jan 1;21(1):60-65. doi: 10.36849/JDD.2022.6632. J Drugs Dermatol. 2022. PMID: 35005863
One clinical trial evaluated the efficacy of calcipotriol plus 5-FU in treating AK. Another clinical trial evaluated the long-term effect of calcipotriol plus 5-FU in prevention of cSCC. ...CONCLUSION: Calcipotriol plus 5-FU reduced greater number of AKs in t …
One clinical trial evaluated the efficacy of calcipotriol plus 5-FU in treating AK. Another clinical trial evaluated the long-term ef …
Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis: A Randomized Clinical Trial.
Santa Lucia G, Snyder A, Lateef A, Drohan A, Gregoski MJ, Barton V, Elston DM. Santa Lucia G, et al. JAMA Dermatol. 2023 May 1;159(5):488-495. doi: 10.1001/jamadermatol.2023.0205. JAMA Dermatol. 2023. PMID: 36947042 Free PMC article. Clinical Trial.
IMPORTANCE: Disseminated superficial actinic porokeratosis (DSAP) is an inherited or sporadic disorder of keratinization associated with germline variations. ...OBJECTIVES: To evaluate and compare the safety and efficacy of topical lovastatin 2% plus cholesterol 2% …
IMPORTANCE: Disseminated superficial actinic porokeratosis (DSAP) is an inherited or sporadic disorder of keratinization associated w …
Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
Gutzmer R, Wiegand S, Kölbl O, Wermker K, Heppt M, Berking C. Gutzmer R, et al. Dtsch Arztebl Int. 2019 Sep 13;116(37):616-626. doi: 10.3238/arztebl.2019.0616. Dtsch Arztebl Int. 2019. PMID: 32048593 Free PMC article. Review.
BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) and its precursors, actinic keratoses (AK), are common. Physicians of multiple specialties are confronted with their treatment. ...RESULTS: Local treatments for AK include lesional cryotherapy, curettage, and laser ablat …
BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) and its precursors, actinic keratoses (AK), are common. Physicians of multiple s …
Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis, Bowen's Disease, and Squamous Cell Carcinoma: A Systematic Review.
Lapidus AH, Lee S, Liu ZF, Smithson S, Chew CY, Gin D. Lapidus AH, et al. J Cutan Med Surg. 2024 Jul-Aug;28(4):375-380. doi: 10.1177/12034754241256347. Epub 2024 May 23. J Cutan Med Surg. 2024. PMID: 38783539 Review.
BACKGROUND/OBJECTIVES: Actinic keratoses (AK) are premalignant skin lesions caused by chronic sun exposure, topically managed by 5-fluorouracil (5-FU), diclofenac 3% gel, and imiquimod. ...
BACKGROUND/OBJECTIVES: Actinic keratoses (AK) are premalignant skin lesions caused by chronic sun exposure, topically managed by 5-fl …
A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
Chen AC, Martin AJ, Choy B, Fernández-Peñas P, Dalziell RA, McKenzie CA, Scolyer RA, Dhillon HM, Vardy JL, Kricker A, St George G, Chinniah N, Halliday GM, Damian DL. Chen AC, et al. N Engl J Med. 2015 Oct 22;373(17):1618-26. doi: 10.1056/NEJMoa1506197. N Engl J Med. 2015. PMID: 26488693 Free article. Clinical Trial.
The primary end point was the number of new nonmelanoma skin cancers (i.e., basal-cell carcinomas plus squamous-cell carcinomas) during the 12-month intervention period. Secondary end points included the number of new squamous-cell carcinomas and basal-cell carcinomas and …
The primary end point was the number of new nonmelanoma skin cancers (i.e., basal-cell carcinomas plus squamous-cell carcinomas) duri …
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
Rosenberg AR, Tabacchi M, Ngo KH, Wallendorf M, Rosman IS, Cornelius LA, Demehri S. Rosenberg AR, et al. JCI Insight. 2019 Mar 21;4(6):e125476. doi: 10.1172/jci.insight.125476. eCollection 2019 Mar 21. JCI Insight. 2019. PMID: 30895944 Free PMC article. Clinical Trial.
BACKGROUND: Topical calcipotriol plus 5-fluorouracil (5-FU) combination is an effective immunotherapy against actinic keratosis (AK), which is a precursor to squamous cell carcinoma (SCC). However, the long-term effectiveness of calcipotriol plus 5-FU treatme …
BACKGROUND: Topical calcipotriol plus 5-fluorouracil (5-FU) combination is an effective immunotherapy against actinic keratosi …
Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy.
Cunningham TJ, Tabacchi M, Eliane JP, Tuchayi SM, Manivasagam S, Mirzaalian H, Turkoz A, Kopan R, Schaffer A, Saavedra AP, Wallendorf M, Cornelius LA, Demehri S. Cunningham TJ, et al. J Clin Invest. 2017 Jan 3;127(1):106-116. doi: 10.1172/JCI89820. Epub 2016 Nov 21. J Clin Invest. 2017. PMID: 27869649 Free PMC article. Clinical Trial.
The efficacy and safety of 0.005% calcipotriol ointment combined with 5% 5-FU cream were compared with Vaseline plus 5-FU for the field treatment of actinic keratosis in a randomized, double-blind clinical trial involving 131 participants. ...RESULTS: Calcipotriol s …
The efficacy and safety of 0.005% calcipotriol ointment combined with 5% 5-FU cream were compared with Vaseline plus 5-FU for the fie …
Bucher's indirect comparison of daylight photodynamic therapy with methyl aminolevulinate cream versus diclofenac plus hyaluronic acid gel for the treatment of multiple actinic keratosis.
Calzavara-Pinton P, Zane C, Pacou M, Szeimies RM. Calzavara-Pinton P, et al. Eur J Dermatol. 2016 Oct 1;26(5):487-492. doi: 10.1684/ejd.2016.2822. Eur J Dermatol. 2016. PMID: 27352420 Review.
Actinic keratosis (AK) is a pre-cancerous condition characterised by patches of thick, scaly skin developing on sun-exposed areas of the body. When multiple AKs develop on severely photodamaged skin, commonly used treatments include photodynamic therapy and diclofenac p
Actinic keratosis (AK) is a pre-cancerous condition characterised by patches of thick, scaly skin developing on sun-exposed areas of
Topical Pharmacotherapy for Actinic Keratoses in Older Adults.
Calzavara-Pinton P, Calzavara-Pinton I, Rovati C, Rossi M. Calzavara-Pinton P, et al. Drugs Aging. 2022 Feb;39(2):143-152. doi: 10.1007/s40266-022-00919-0. Epub 2022 Feb 14. Drugs Aging. 2022. PMID: 35156172 Free PMC article. Review.
Actinic keratosis is caused by excessive lifetime sun exposure. It must be treated, regardless of thickness, because it is the biologic precursor of invasive squamous cell carcinoma, a potentially deadly malignancy. ...Drug preparations containing diclofenac plus hy
Actinic keratosis is caused by excessive lifetime sun exposure. It must be treated, regardless of thickness, because it is the biolog
116 results